Nordhydrogensp. z o.o.
Other research and experimental development on natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2013-07-03
Share capital
5 000,00 PLN
Registered address
al. Jerozolimskie 65/79, 00-697 Warszawa, Poland
Financials
Revenue history
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Industry
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Krzysztof Jerzy Niedbalski — President of the Management Board
Manfred Wilhelm Schatovich — Management Board Member
Manner of representation
Two members of the management board acting jointly are authorized to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 34 | $459.21 | 34% | |
Krzysztof Jerzy Niedbalski (66) | 33 | $445.71 | 33% |
Manfred Wilhelm Schatovich (66) | 33 | $445.71 | 33% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Krzysztof Jerzy Niedbalski (66) | Shareholder of a limited liability company, 3250.0 PLN | |
Manfred Wilhelm Schatovich (66) | Shareholder of a limited liability company, 1750.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedicalgorithmicsS.A. | $7,566,549.47 | medicalgorithmics.com | ||
| Clinchoicesp. z o.o. | $2,048,208.30 | clinchoice.com | ||
| Retailicsp. z o.o. | $637,675.32 | retailic.com | ||
| Airway MedixS.A. | $512,838.82 | airway-medix.com | ||
| CTI Clinical Trial And Consulting Services Polandsp. z o.o. | $527,145.56 | ctifacts.com | ||
| Cezamat Pwsp. z o.o. | $119,656.05 | cezamat.eu | ||
| Bacteromicsp. z o.o. | $112,732.71 | bacteromic.com | ||
| Microanalysissp. z o.o. | $1,425.98 | microanalysis.pl | ||
| Global Business Promotion Groupsp. z o.o. | — | globalbpg.com | ||
| JLDAsp. z o.o. | — | jlda.eu |
Change history
| Date | Event | |
|---|---|---|
| 2022-05-09 | Name change (Nordpharm → Nordhydrogen) | |
| 2015-08-21 | Name change (K.n.i. → Nordpharm) | |
| 2015-08-21 | PKD change (Removed: 41.10.Z, 41.20.Z, 43.11.Z, 43.12.Z, 43.13.Z, 43.21.Z, 43.22.Z, 43.29.Z, 47.74.Z, 68.10.Z, 68.20.Z, 70.10.Z, 70.21.Z, 70.22.Z, 71.11.Z, 71.12.Z; Added: 10.32.Z, 11.07.Z, 21, 46.34.B, 46.39.Z, 46.46.Z, 47.73.Z, 47.81.Z, 72.11.Z, 72.19.Z) | |
| 2013-07-03 | Entered in the register |
FAQ
The main business activity of Nordhydrogen focuses on other research and experimental development on natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on July 3, 2013.
The headquarters is located at: Al. Jerozolimskie 65/79, 00-697 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Last updated: 2026-06-18